US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Everus Construction Group, Inc.

115.13

-0.6000-0.52%

Pre-market: 113.58-1.5500-1.35%08:21 EDT

Volume:499.90K

Turnover:57.42M

Market Cap:5.87B

PE:23.12

High:117.38

Open:116.24

Low:114.08

Close:115.73

52wk High:171.58

52wk Low:73.00

Shares:51.01M

Float Shares:50.85M

Volume Ratio:0.99

T/O Rate:0.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):4.98

EPS(LYR):3.95

ROE:39.52%

ROA:11.68%

PB:7.59

PE(LYR):29.15

Loading ...

Overview Company News Filings

European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents

Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026

Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

Everus Construction promotes Jason Behring to CIO, Britney Hendricks to CHRO

Everus names Jason Behring chief information officer

Everus Announces Promotions of Behring, Hendricks

THOMSON REUTERS

Everus Construction Group: Secular Growth Tailwinds and Dual-Segment Strength Support Buy Rating and $185 Price Target

Everus Construction posts investor presentation outlining national construction-services platform, growth strategy

Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Everus CEO, CFO to attend KeyBanc Industrials & Basic Materials Conference

Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC

Everus Construction Group holds annual shareholder meeting

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition

Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026

Everus Construction Group Is Maintained at Neutral by Cantor Fitzgerald

Guggenheim Sticks to Its Buy Rating for Everus Construction Group, Inc. (ECG)

HeartBeam (NASDAQ: BEAT) Tackles Heart Disease with Next-Generation ECG Solutions

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ECG/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ECG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ECG\",,,,,undefined,":{"symbol":"ECG","market":"US","secType":"STK","nameCN":"Everus Construction Group, Inc.","latestPrice":115.13,"timestamp":1788206400000,"preClose":115.73,"halted":0,"volume":499896,"hourTrading":{"tag":"盘前","latestPrice":113.58,"preClose":115.13,"latestTime":"08:21 EDT","volume":90,"amount":10356.9327,"timestamp":1788265285091,"change":-1.55,"changeRate":-0.013463,"amplitude":0.013463},"delay":0,"changeRate":-0.005184481119847996,"floatShares":50847531,"shares":51006575,"eps":4.980016,"marketStatus":"Pre-Mkt","change":-0.6,"latestTime":"09-01 08:23:39 EDT","open":116.24,"high":117.38,"low":114.075,"amount":57417674.63904,"amplitude":0.028558,"askPrice":128.63,"askSize":100,"bidPrice":96.03,"bidSize":100,"shortable":3,"etf":0,"ttmEps":4.980016,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":115.13,"preHourTrading":{"tag":"盘前","latestPrice":113.58,"preClose":115.13,"latestTime":"08:21 EDT","volume":90,"amount":10356.9327,"timestamp":1788265285091,"change":-1.55,"changeRate":-0.013463,"amplitude":0.013463},"postHourTrading":{"tag":"盘后","latestPrice":115.13,"preClose":115.13,"latestTime":"19:30 EDT","volume":24322,"amount":2800098.656692,"timestamp":1788219007553,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9947874231530611,"impliedVol":0.5788,"impliedVolPercentile":0.4622},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ECG\",,,,,undefined,":{"symbol":"ECG","floatShares":50847531,"roa":"11.68%","roe":"39.52%","lyrEps":3.95,"volumeRatio":0.9947874231530611,"shares":51006575,"dividePrice":0,"high":117.38,"amplitude":0.028558,"preClose":115.73,"low":114.075,"week52Low":73,"pbRate":"7.59","psRate":"1.38","week52High":171.577,"institutionHeld":0,"latestPrice":115.13,"eps":4.980016,"divideRate":0,"volume":499896,"delay":0,"ttmEps":4.980016,"open":116.24,"prevYearClose":85.56,"prevWeekClose":115.73,"prevMonthClose":115.13,"prevQuarterClose":165.95,"fiveDayClose":120.5,"twentyDayClose":132.62,"sixtyDayClose":154.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ECG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"ECG","fiscalQuarterEnding":"2026/06","expectedEps":1.1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":1.64},{"market":"US","date":"2026-05-05","symbol":"ECG","fiscalQuarterEnding":"2026/03","expectedEps":0.76,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":1.14},{"date":"2026-02-24","symbol":"ECG","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":0.72,"defaultRemindTime":1771966800000,"name":null,"time":"Post-Mkt","dateTimestamp":1771909200000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"ECG","fiscalQuarterEnding":"2025/09","expectedEps":0.62,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":1.11},{"market":"US","date":"2025-08-12","symbol":"ECG","fiscalQuarterEnding":"2025/06","expectedEps":0.61,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":1.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ECG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ECG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.25,"hold":0.375,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":8,"updateTime":1787457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ECG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ECG","date":"2026-08-28","current":23.1184,"percent":0.383929,"low":11.94786,"twenty":22.666157,"median":25.200171,"eighty":29.769879,"high":38.646629,"avg":25.395722,"sd":5.873979,"marketCap":6180766709},"quantilePoints":[{"date":"2024-11-15","current":19.884731,"twenty":20.580031,"median":21.388177,"eighty":22.118522,"marketCap":2892154627},{"date":"2024-11-22","current":22.527151,"twenty":20.580031,"median":21.221711,"eighty":22.118522,"marketCap":3276483952},{"date":"2024-11-29","current":22.309869,"twenty":20.774883,"median":21.784189,"eighty":22.44935,"marketCap":3244881275},{"date":"2024-12-06","current":23.914946,"twenty":20.948708,"median":22.309869,"eighty":22.694667,"marketCap":3478333306},{"date":"2024-12-13","current":24.1112,"twenty":21.255005,"median":22.386969,"eighty":23.504916,"marketCap":3506877659},{"date":"2024-12-20","current":22.639296,"twenty":21.463875,"median":22.621773,"eighty":23.900227,"marketCap":3292795011},{"date":"2024-12-27","current":25.796882,"twenty":21.726014,"median":22.804009,"eighty":24.031297,"marketCap":3752053262},{"date":"2025-01-03","current":24.279418,"twenty":22.045628,"median":23.042317,"eighty":24.098584,"marketCap":3531344247},{"date":"2025-01-10","current":23.36123,"twenty":22.054038,"median":23.36123,"eighty":24.167273,"marketCap":3397797452},{"date":"2025-01-17","current":23.231562,"twenty":22.309869,"median":23.296396,"eighty":24.223346,"marketCap":3378937791},{"date":"2025-01-24","current":26.403166,"twenty":22.309869,"median":23.448843,"eighty":24.416796,"marketCap":3840234925},{"date":"2025-01-31","current":24.703467,"twenty":22.363139,"median":23.511925,"eighty":24.431515,"marketCap":3593020438},{"date":"2025-02-07","current":24.784071,"twenty":22.393278,"median":23.631079,"eighty":24.431515,"marketCap":3604744012},{"date":"2025-02-14","current":17.609659,"twenty":22.363139,"median":23.694161,"eighty":24.484083,"marketCap":2525594974},{"date":"2025-02-21","current":16.543269,"twenty":22.049833,"median":23.511925,"eighty":24.443431,"marketCap":2372652202},{"date":"2025-02-28","current":14.893919,"twenty":20.948708,"median":23.398027,"eighty":24.417497,"marketCap":2136100715},{"date":"2025-03-07","current":14.060071,"twenty":19.828659,"median":23.326185,"eighty":24.358924,"marketCap":2016509475},{"date":"2025-03-14","current":13.437787,"twenty":16.836882,"median":23.135188,"eighty":24.308591,"marketCap":1927260826},{"date":"2025-03-21","current":14.294761,"twenty":15.304834,"median":22.94419,"eighty":24.287829,"marketCap":2050168965},{"date":"2025-03-28","current":12.43502,"twenty":14.540119,"median":22.651562,"eighty":24.245775,"marketCap":1783443003},{"date":"2025-04-04","current":12.555921,"twenty":14.128344,"median":22.527151,"eighty":24.214935,"marketCap":1800782740},{"date":"2025-04-11","current":13.501793,"twenty":13.910012,"median":22.343162,"eighty":24.184095,"marketCap":1936440687},{"date":"2025-04-17","current":13.572911,"twenty":13.722422,"median":22.181953,"eighty":24.146246,"marketCap":1946640532},{"date":"2025-04-25","current":14.568566,"twenty":13.695946,"median":21.51434,"eighty":24.113303,"marketCap":2089438371},{"date":"2025-05-02","current":15.233522,"twenty":13.71017,"median":20.922073,"eighty":24.085968,"marketCap":2184806927},{"date":"2025-05-09","current":17.164381,"twenty":13.722422,"median":19.902399,"eighty":24.031297,"marketCap":2461732735},{"date":"2025-05-16","current":20.563833,"twenty":13.745616,"median":19.893565,"eighty":23.999055,"marketCap":3123214340},{"date":"2025-05-23","current":21.992869,"twenty":13.78911,"median":20.563833,"eighty":23.959104,"marketCap":2926865953},{"date":"2025-05-30","current":22.176813,"twenty":13.823958,"median":20.788901,"eighty":23.91004,"marketCap":2951345752},{"date":"2025-06-06","current":23.146354,"twenty":13.877297,"median":21.451259,"eighty":23.877799,"marketCap":3080374692},{"date":"2025-06-13","current":23.161683,"twenty":13.948415,"median":21.770602,"eighty":23.816119,"marketCap":3082414675},{"date":"2025-06-20","current":22.912591,"twenty":13.971173,"median":22.043525,"eighty":23.771261,"marketCap":3049264947},{"date":"2025-06-27","current":23.740342,"twenty":14.060071,"median":22.121246,"eighty":23.740342,"marketCap":3159424042},{"date":"2025-07-03","current":24.970471,"twenty":14.07145,"median":22.251005,"eighty":23.895321,"marketCap":3323132697},{"date":"2025-07-11","current":25.805886,"twenty":14.153947,"median":22.376456,"eighty":24.052477,"marketCap":3434311784},{"date":"2025-07-18","current":26.518671,"twenty":14.202307,"median":22.526346,"eighty":24.175684,"marketCap":3529171005},{"date":"2025-07-25","current":26.442027,"twenty":14.212264,"median":22.621773,"eighty":24.30109,"marketCap":3518971089},{"date":"2025-08-01","current":28.457753,"twenty":14.278404,"median":22.671329,"eighty":24.416796,"marketCap":3787228885},{"date":"2025-08-08","current":27.411568,"twenty":14.30614,"median":22.782297,"eighty":24.537352,"marketCap":3648000028},{"date":"2025-08-15","current":23.175295,"twenty":14.422774,"median":22.810398,"eighty":24.635911,"marketCap":3841305163},{"date":"2025-08-22","current":23.323006,"twenty":14.493892,"median":22.904927,"eighty":24.537352,"marketCap":3865788319},{"date":"2025-08-29","current":24.713955,"twenty":14.521629,"median":22.920255,"eighty":24.537352,"marketCap":4096338038},{"date":"2025-09-05","current":23.815378,"twenty":14.551498,"median":22.978193,"eighty":24.507914,"marketCap":3947398839},{"date":"2025-09-12","current":24.372372,"twenty":14.649641,"median":23.042317,"eighty":24.488989,"marketCap":4039720740},{"date":"2025-09-19","current":25.200171,"twenty":14.753844,"median":23.089828,"eighty":24.488989,"marketCap":4176928426},{"date":"2025-09-26","current":24.396991,"twenty":14.851263,"median":23.146354,"eighty":24.588002,"marketCap":4043801266},{"date":"2025-10-03","current":25.117084,"twenty":14.97923,"median":23.180649,"eighty":24.722376,"marketCap":4163156651},{"date":"2025-10-10","current":27.003481,"twenty":15.154555,"median":23.193759,"eighty":24.845751,"marketCap":4475826956},{"date":"2025-10-17","current":27.852821,"twenty":15.383802,"median":23.275964,"eighty":25.02914,"marketCap":4616605103},{"date":"2025-10-24","current":26.926548,"twenty":15.791108,"median":23.323006,"eighty":25.217404,"marketCap":4463075312},{"date":"2025-10-31","current":27.600481,"twenty":16.024903,"median":23.341955,"eighty":25.414653,"marketCap":4574779711},{"date":"2025-11-07","current":27.713121,"twenty":16.093341,"median":23.36123,"eighty":25.523906,"marketCap":5014966454},{"date":"2025-11-14","current":25.813341,"twenty":16.136723,"median":23.428153,"eighty":25.800484,"marketCap":4671182138},{"date":"2025-11-21","current":22.66771,"twenty":16.383495,"median":23.439945,"eighty":25.708429,"marketCap":4101948761},{"date":"2025-11-28","current":25.92045,"twenty":16.548957,"median":23.449096,"eighty":25.737913,"marketCap":4690564637},{"date":"2025-12-05","current":26.630754,"twenty":16.561288,"median":23.487393,"eighty":25.810359,"marketCap":4819101206},{"date":"2025-12-12","current":28.527716,"twenty":16.749451,"median":23.659866,"eighty":25.855971,"marketCap":5162375455},{"date":"2025-12-19","current":24.578765,"twenty":17.031279,"median":23.716749,"eighty":25.83416,"marketCap":4447773340},{"date":"2025-12-26","current":25.272157,"twenty":17.057186,"median":23.738426,"eighty":25.81185,"marketCap":4573249514},{"date":"2026-01-02","current":24.116504,"twenty":17.112011,"median":23.784087,"eighty":25.805886,"marketCap":4364122557},{"date":"2026-01-09","current":24.601314,"twenty":17.164381,"median":23.827333,"eighty":25.805886,"marketCap":4451853866},{"date":"2026-01-16","current":25.170685,"twenty":17.266247,"median":23.880592,"eighty":25.796882,"marketCap":4554887147},{"date":"2026-01-23","current":25.948637,"twenty":17.540977,"median":23.951744,"eighty":25.84491,"marketCap":4695665294},{"date":"2026-01-30","current":25.940181,"twenty":17.774022,"median":24.037581,"eighty":25.850684,"marketCap":4694135097},{"date":"2026-02-06","current":25.07485,"twenty":19.358663,"median":24.060792,"eighty":25.850684,"marketCap":4537544912},{"date":"2026-02-13","current":28.544628,"twenty":19.856695,"median":24.113685,"eighty":25.941872,"marketCap":5165435850},{"date":"2026-02-20","current":29.463513,"twenty":19.895332,"median":24.116504,"eighty":26.181969,"marketCap":5331717284},{"date":"2026-02-27","current":30.881602,"twenty":20.109789,"median":24.148919,"eighty":26.329202,"marketCap":6230980793},{"date":"2026-03-06","current":28.303079,"twenty":20.437519,"median":24.175424,"eighty":26.394077,"marketCap":5710712259},{"date":"2026-03-13","current":28.548292,"twenty":20.677847,"median":24.216336,"eighty":26.448787,"marketCap":5760188776},{"date":"2026-03-20","current":29.706099,"twenty":20.774883,"median":24.279418,"eighty":26.529401,"marketCap":5993799549},{"date":"2026-03-27","current":29.094332,"twenty":20.948708,"median":24.302633,"eighty":26.689853,"marketCap":5870363289},{"date":"2026-04-02","current":31.722344,"twenty":21.188418,"median":24.333318,"eighty":26.916253,"marketCap":6400617392},{"date":"2026-04-10","current":32.972012,"twenty":21.438642,"median":24.367365,"eighty":27.26095,"marketCap":6652762926},{"date":"2026-04-17","current":32.00567,"twenty":21.599983,"median":24.390836,"eighty":27.510741,"marketCap":6457783991},{"date":"2026-04-24","current":34.487298,"twenty":21.74531,"median":24.416095,"eighty":27.668065,"marketCap":6958502145},{"date":"2026-05-01","current":37.295257,"twenty":21.859509,"median":24.449388,"eighty":27.82041,"marketCap":7525063972},{"date":"2026-05-08","current":36.192948,"twenty":22.013131,"median":24.514222,"eighty":27.962617,"marketCap":8086011222},{"date":"2026-05-15","current":36.814364,"twenty":22.04773,"median":24.569427,"eighty":28.043615,"marketCap":8224844390},{"date":"2026-05-22","current":34.431506,"twenty":22.058695,"median":24.629872,"eighty":28.172029,"marketCap":7692480440},{"date":"2026-05-29","current":34.614275,"twenty":22.087907,"median":24.649232,"eighty":28.276876,"marketCap":7733313725},{"date":"2026-06-05","current":35.356777,"twenty":22.179879,"median":24.701718,"eighty":28.451451,"marketCap":7899198944},{"date":"2026-06-12","current":32.827703,"twenty":22.215687,"median":24.735008,"eighty":28.547559,"marketCap":7334168366},{"date":"2026-06-18","current":35.240261,"twenty":22.309869,"median":24.784071,"eighty":28.770121,"marketCap":7873167725},{"date":"2026-06-26","current":37.367242,"twenty":22.309869,"median":24.890996,"eighty":28.957822,"marketCap":8348365077},{"date":"2026-07-02","current":34.502329,"twenty":22.363139,"median":24.956422,"eighty":29.28494,"marketCap":7708303338},{"date":"2026-07-10","current":31.67397,"twenty":22.393278,"median":24.973378,"eighty":29.488267,"marketCap":7076408255},{"date":"2026-07-17","current":30.718999,"twenty":22.499929,"median":25.033154,"eighty":29.681878,"marketCap":6863054342},{"date":"2026-07-24","current":31.5209,"twenty":22.526829,"median":25.094581,"eighty":30.04842,"marketCap":7042210379},{"date":"2026-07-31","current":28.087116,"twenty":22.572171,"median":25.117084,"eighty":29.95643,"marketCap":6275055041},{"date":"2026-08-07","current":28.000114,"twenty":22.613938,"median":25.15941,"eighty":30.056374,"marketCap":7124937037},{"date":"2026-08-14","current":27.592745,"twenty":22.632287,"median":25.200171,"eighty":29.95643,"marketCap":7021277450},{"date":"2026-08-21","current":25.148529,"twenty":22.654015,"median":25.245022,"eighty":29.879492,"marketCap":6399319927},{"date":"2026-08-28","current":24.289642,"twenty":22.666157,"median":25.200171,"eighty":29.769879,"marketCap":6180766709}],"updateTime":1788233787329},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ECG\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642282334","title":"European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents","url":"https://stock-news.laohu8.com/highlight/detail?id=2642282334","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642282334?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:30","pubTimestamp":1781181000,"startTime":"0","endTime":"0","summary":"Patent covers machine-learning models that use ECG data to estimate echocardiogram parameters indicative of diastolic functionSouthlake, TX, June  11, 2026  (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/11/3310452/0/en/European-Patent-Granted-for-ECG-Based-Assessment-of-Diastolic-Function-Expands-HeartSciences-Patent-Portfolio-to-More-Than-45-Granted-Patents.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","EPV","LU0566484027.USD","ECG","BK4129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289420","title":"Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289420","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642289420?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:03","pubTimestamp":1781175780,"startTime":"0","endTime":"0","summary":"–Real-world study of revumenib shows 82% (9/11) ORR and 64% (7/11) CR/CRh rate among R/R NPM1m or KMT2Ar patients treated with revumenib monotherapy or combinations – –Ph 1 trial of revumenib with int","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/11/3310342/0/en/Syndax-Showcases-Revuforj-revumenib-Clinical-Activity-in-Multiple-Acute-Leukemia-Subtypes-and-Settings-at-EHA-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR","BK4161","BK4500","BK4129","BK4533","ORR","HSCT","LU0985320562.USD","LU1571399168.USD","SAVE","BK4107","LU2355687059.USD","BK4008","ECG","LU0566484027.USD","BK4585","BK4588","ALL","LU1699723380.USD","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640116923","title":"Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2640116923","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640116923?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:01","pubTimestamp":1780430460,"startTime":"0","endTime":"0","summary":"– Pooled analysis of 24 adults and children with KMT2Ar, NPM1m, or NUP98r acute leukemia who resumed revumenib post-transplant shows favorable outcomes, including a2-year overall survival rate of 90% ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/02/3305568/0/en/Syndax-Highlights-Revuforj-revumenib-Data-Presented-at-ASCO-2026-Including-an-Oral-Presentation-of-Post-Transplant-Data.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4218","LU1559883803.SGD","BK4533","BK4212","BK4129","LU1571399168.USD","POST","PK","HSCT","BK4588","BK4585","ALL","BK4181","LU0985320562.USD","LU0566484027.USD","ECG","LU2355687059.USD","LU1699723380.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640940224","title":"HeartBeam (NASDAQ: BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2640940224","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640940224?lang=en_us&edition=fundamental","pubTime":"2026-06-03 02:30","pubTimestamp":1780425024,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, June 2nd, 2026, FinanceWire HeartBeam (NASDAQ:BEAT) a medical technology company focused on transforming cardiac...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/heartbeam-nasdaq-beat-study-shows-portable-ecg-device-can-help-identify-heart-attack-risk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/heartbeam-nasdaq-beat-study-shows-portable-ecg-device-can-help-identify-heart-attack-risk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0566484027.USD","MNQmain","QQQY","GPIQ","SQQQ","TQQY","JEPQ","ECG","ONEQ","TQQQ","QQQM","LU1559883803.SGD","QQQE","NDX","QLD","TECS","BEAT","BK4082",".IXIC","BK4129","QQQ","FTEC","PSQ","QQQJ","QID","IYW","QYLG","QDTE","NQmain","QQQA","NVIW.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640943876","title":"HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm","url":"https://stock-news.laohu8.com/highlight/detail?id=2640943876","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640943876?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:30","pubTimestamp":1780403400,"startTime":"0","endTime":"0","summary":"Bunkerhill Health’s FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first cleared AI-ECG algorithm available through MyoVista Insights, advancing HeartSciences’","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/02/3305156/0/en/HeartSciences-Launches-MyoVista-Insights-Version-1-3-with-AI-ECG-Algorithm-Marketplace-and-First-FDA-Cleared-Algorithm.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIYY","LABU","SPYU","SPY","AGIX","LU1066051498.USD","BK4585","LU1674673691.USD","YSPY","ARTY","SMAX","HIBL","AI","LU2236285917.USD","SPYQ","SPXL","LU2417539215.USD","SPDN","UPRO","LU1718418525.SGD","SDS","LU1366333091.USD","IVV","AIPO","LU2237443549.SGD","LU1066051225.USD","LU1559883803.SGD","SPXS","LU1935042991.SGD","BK4023","SPUU","VOO","MMAX","ECG","SPXU","APC","LU1778281490.HKD","SH","DMAX","SSO","LU1066051811.HKD","LU2456880835.USD","LU1935043536.SGD","SPYM","LU1674673428.USD","BK4129","CHAT","LU0170899867.USD","LU1935042488.USD","SPYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640968641","title":"Everus Construction promotes Jason Behring to CIO, Britney Hendricks to CHRO","url":"https://stock-news.laohu8.com/highlight/detail?id=2640968641","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640968641?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:56","pubTimestamp":1780325773,"startTime":"0","endTime":"0","summary":"Everus Construction (ECG) Group announced that Vice President of Technology Jason Behring has been promoted to vice president and chief information...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/everus-construction-promotes-jason-behring-to-cio-britney-hendricks-to-chro-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/everus-construction-promotes-jason-behring-to-cio-britney-hendricks-to-chro-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4194","BK4223","CIO","ECG","LU1559883803.SGD","BK4129","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640595143","title":"Everus names Jason Behring chief information officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640595143","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640595143?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:30","pubTimestamp":1780317027,"startTime":"0","endTime":"0","summary":"Everus promoted Jason A. Behring to vice president and chief information officer from vice president of technology.Behring joined the company in 1999, holding various IT roles.Britney A. Hendricks was elevated to vice president and chief human resources officer from vice president of human resources.Hendricks joined the company in 2019, holding various human resources roles.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everus Construction Group Inc. published the original content used to generate this news brief via Business Wire  on June 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL4dzHxC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","ECG","BK4129","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640795190","title":"Everus Announces Promotions of Behring, Hendricks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640795190","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640795190?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:30","pubTimestamp":1780317000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUA5K0QV1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1559883803.SGD","ECG","BK4129","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639642363","title":"Everus Construction Group: Secular Growth Tailwinds and Dual-Segment Strength Support Buy Rating and $185 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2639642363","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639642363?lang=en_us&edition=fundamental","pubTime":"2026-05-29 14:55","pubTimestamp":1780037758,"startTime":"0","endTime":"0","summary":"Everus Construction Group, Inc. (ECG) has received a new Buy rating, initiated by Oppenheimer analyst, Brent Thielman. Brent Thielman has given his...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/everus-construction-group-secular-growth-tailwinds-and-dual-segment-strength-support-buy-rating-and-185-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/everus-construction-group-secular-growth-tailwinds-and-dual-segment-strength-support-buy-rating-and-185-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ECG","BK4129","LU1559883803.SGD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638540087","title":"Everus Construction posts investor presentation outlining national construction-services platform, growth strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2638540087","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638540087?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:23","pubTimestamp":1779827023,"startTime":"0","endTime":"0","summary":"Everus Construction Group outlined a scaled platform of 20 local brands with about 9,400 employees; about 85% unionized.Trailing 12-month revenue totaled USD 3.96 billion; Electrical & Mechanical contributed USD 3.11 billion with 8.8% EBITDA margin.Transmission & Distribution posted USD 868 million revenue with 14% EBITDA margin; about 55% of segment revenue tied to MSAs.Backlog stood at USD 3.68 billion as of March 31, 2026; Electrical & Mechanical accounted for USD 3.29 billion.First-quarter 2026 revenue rose 25% to USD 1.04 billion; EBITDA climbed 44% to USD 88.9 million with margin at 8.6%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everus Construction Group Inc. published the original content used to generate this news brief o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL3MFDQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","ECG","BK4129","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357561","title":"Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357561","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357561?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:01","pubTimestamp":1779397260,"startTime":"0","endTime":"0","summary":"– Oral presentation will highlight favorable outcomes observed among 21 adults and children with KMT2Ar, NPM1m, or NUP98r acute leukemia who received revumenib post-transplant – – Data underscoring un","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299789/0/en/Syndax-Announces-Four-Revuforj-revumenib-Abstracts-Accepted-for-ASCO-2026-Including-an-Oral-Presentation-of-Post-Transplant-Data.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POST","LU0566484027.USD","BK4107","LU1559883803.SGD","LU0985320562.USD","PK","BK4585","HSCT","BK4588","LU1571399168.USD","LU2355687059.USD","ALL","BK4533","BK4181","BK4129","LU1699723380.USD","BK4212","BK4218","ECG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636586425","title":"Everus CEO, CFO to attend KeyBanc Industrials & Basic Materials Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2636586425","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636586425?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:30","pubTimestamp":1779222641,"startTime":"0","endTime":"0","summary":"Everus Construction Group executives are scheduled to attend the KeyBanc Capital Markets Industrials & Basic Materials Conference on May 27 in Boston.The company is also slated to participate in the Stifel 2026 Cross Sector Insight Conference on June 2, also in Boston.President and CEO Jeffrey S. Thiede is set to appear alongside CFO Maximillian J Marcy, with one-on-one investor meetings planned around the events.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everus Construction Group Inc. published the original content used to generate this news brief via Business Wire  on May 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL9KhH1W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211326755.USD","KEY","LU0310800965.SGD","LU0128525689.USD","BK4585","LU0976567544.SGD","ECG","LU0496365809.HKD","LU1267930227.SGD","LU0211326839.USD","LU0052756011.USD","BK4589","LU0566484027.USD","LU1559883803.SGD","BK4129","BK4207","BK4211","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635088937","title":"Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC","url":"https://stock-news.laohu8.com/highlight/detail?id=2635088937","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635088937?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:01","pubTimestamp":1778839260,"startTime":"0","endTime":"0","summary":"All Patients Achieved Meaningful Decreases (Mean = 64%) in Daily Premature Ventricular Contraction Count TN-401 Gene Therapy was Well Tolerated at 3E13 vg/kg and 6E13 vg/kg Doses Post-dose Biopsies Pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/15/3295666/0/en/Positive-Interim-Data-from-Cohorts-1-and-2-of-Tenaya-s-RIDGE-1-Phase-1b-2-Clinical-Trial-of-TN-401-Demonstrated-Consistent-Reductions-in-Arrhythmia-Burden-for-Adults-with-PKP2-asso.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK4539","HCM","LU0566484027.USD","BK4129","BK4007","BK4588","TNYA","BK4531","EMA","BK4585","BK4139","ECG","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635487725","title":"Everus Construction Group holds annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2635487725","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635487725?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:24","pubTimestamp":1778790287,"startTime":"0","endTime":"0","summary":"Everus Construction Group held annual stockholder meeting on May 12, 2026.Non-binding advisory resolution on executive pay was adopted.Appointment of KPMG as independent registered public accounting firm for 2026 was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everus Construction Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDLdy9gb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","BK4129","LU1559883803.SGD","ECG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635899437","title":"Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635899437","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635899437?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:11","pubTimestamp":1778670660,"startTime":"0","endTime":"0","summary":"CARDAMYST (etripamil) nasal spray launch for PSVT isgaining traction; breadth of unique prescribers supportspotential future adoptionExpress Scripts national formulary coverage secured as company make","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293867/0/en/Milestone-Pharmaceuticals-Announces-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1559883803.SGD","EMA","LU0566484027.USD","BK4081","BK4129","MAA","BK4588","AV","ECG","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634248833","title":"Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition","url":"https://stock-news.laohu8.com/highlight/detail?id=2634248833","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634248833?lang=en_us&edition=fundamental","pubTime":"2026-05-12 22:31","pubTimestamp":1778596260,"startTime":"0","endTime":"0","summary":"– Abstracts highlight strong revumenib activity across the acute leukemia treatment continuum and multiple genetic subtypes – – New real-world data show compelling outcomes and favorable tolerability ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293092/0/en/Syndax-Highlights-12-Revuforj-revumenib-Abstracts-Accepted-for-EHA-2026-Advancing-Leadership-in-Menin-Inhibition.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","ECG","BK4500","BK4533","ALL","LU0985320562.USD","SAVE","HSCT","BK4008","BK4129","LU2355687059.USD","LU1559883803.SGD","BK4588","BK4107","LU1699723380.USD","LU1571399168.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634280108","title":"Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634280108","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634280108?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:06","pubTimestamp":1778508360,"startTime":"0","endTime":"0","summary":"Multinational Real-world Data Reinforce Favorable Clinical Profile and Long-Term Safety SOUTH SAN FRANCISCO, Calif., May  11, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3292055/35409/en/Cytokinetics-Announces-New-Data-Related-to-MYQORZO-aficamten-at-ESC-Heart-Failure-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCM","LU0566484027.USD","BK4129","BK4007","BK4588","BK4531","BK4585","BK4139","ECG","BK4505","CYTK","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634287891","title":"Everus Construction Group Is Maintained at Neutral by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2634287891","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634287891?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:45","pubTimestamp":1778507100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ECG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 09:45 ET (13:45 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4129","LU0566484027.USD","ECG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633194809","title":"Guggenheim Sticks to Its Buy Rating for Everus Construction Group, Inc. (ECG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633194809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633194809?lang=en_us&edition=fundamental","pubTime":"2026-05-07 13:57","pubTimestamp":1778133442,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Joseph Osha from Guggenheim maintained a Buy rating on Everus Construction Group, Inc., with a price target of $160...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-buy-rating-for-everus-construction-group-inc-ecg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-buy-rating-for-everus-construction-group-inc-ecg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ECG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633713027","title":"HeartBeam (NASDAQ: BEAT) Tackles Heart Disease with Next-Generation ECG Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2633713027","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633713027?lang=en_us&edition=fundamental","pubTime":"2026-05-07 00:30","pubTimestamp":1778085035,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, May 6th, 2026, FinanceWire Cardiovascular disease remains the leading cause of death in the United States. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/heartbeam-nasdaq-beat-tackles-heart-disease-with-next-generation-ecg-solutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/heartbeam-nasdaq-beat-tackles-heart-disease-with-next-generation-ecg-solutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TQQY","BK4082","GPIQ","NQmain","SQQQ",".IXIC","JEPQ","FTEC","TQQQ","PSQ","QYLG","IYW","QQQY","LU0566484027.USD","NVIW.SI","BEAT","ECG","LU1559883803.SGD","QQQA","QQQJ","QQQM","NDX","QID","QDTE","MNQmain","QQQ","QQQE","ONEQ","BK4129","QLD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":99,"code":"91000000","status":"200"}]}}